NeuroSense Therapeutics Ltd. Insider Trading
NRSN
Insiders bought 400K on the open market and sold nothing.
Get an email when NRSN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16 | Alon Ben-Noon Chief Executive Officer | Bought | 250,000 | $0.80 | 200K | 5.8% | Form 4 |
| Jun 16 | Or Eisenberg Chief Financial Officer | Bought | 250,000 | $0.80 | 200K | 20% | Form 4 |
- Jun 16Alon Ben-NoonChief Executive Officer · bought 250,000 at $0.80200K5.8% of stake
- Jun 16Or EisenbergChief Financial Officer · bought 250,000 at $0.80200K20% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with NRSN
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NRSN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.